Industries > Pharma > Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing

PUBLISHED: 27 September 2016
PAGES: 317
PRODUCT CODE: PHA0145
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0145 Categories: ,

In its updated report, Visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market.

This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown by more than 6% from 2014.

The new study predicts strong growth in that industry’s revenue, reaching $84.0bn worldwide in 2020, with further expansion expected.

Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies.

The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
• Overview of the company’s contract manufacturing services and operations
• Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2015 onwards
Forecasting of pharmaceutical manufacturing revenue to 2026, as well as projected operating profit and margin for some companies.

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

Leading Pharmaceutical Contract Manufacturing Organisations profiled in this report:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy’s Laboratories

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026


Latest Pharma news

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022

READ

Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022

READ

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

READ

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Categories